Literature DB >> 18004634

MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain : A review of reported findings.

A Seewann1, C Enzinger, M Filippi, F Barkhof, A Rovira, A Gass, D Miller, X Montalban, A Thompson, T Yousry, M Tintore, N de Stefano, J Palace, M Rovaris, C Polman, F Fazekas.   

Abstract

BACKGROUND: Idiopathic inflammatory demyelinating lesions (IIDL) of the brain usually present with a morphologic pattern characteristic of multiple sclerosis (MS). Atypical appearances of IIDLs also exist, however, and can pose significant diagnostic problems and uncertainty regarding prognosis and adequate therapy. We attempted to improve upon this situation by reviewing the literature.
METHODS: We performed a PubMed search from January 1984 through December 2004 for articles in English reporting on IIDLs which had been considered as morphologically atypical (66 articles; 270 cases reported). From these publications 69 individual patient reports allowed the extraction of adequate information on magnetic resonance imaging (MRI) and associated disease characteristics.
RESULTS: Reported atypical IIDLs most frequently manifested as large ring-like lesions (n = 27) which are now considered quite suggestive of an antibodymediated form of MS. Truly atypical IIDLs were less common and exhibited appearances which we termed megacystic (n = 8), Balolike (n = 11) and diffusely infiltrating (n = 11). Despite limitations imposed by the absence of original data the inter-rater agreement in defining these subtypes of atypical IIDLs was moderate to substantial (kappa 0.48-0.68) and we noted trends for their association with certain demographic, clinical and paraclinical variables.
INTERPRETATION: We suggest that IIDLs reported as atypical in the literature can be segregated into several distinct subtypes based on their MRI appearance. The recognition of these patterns may be useful for the differential diagnosis and for a future classification. Because of the limitations inherent in our review this will have to be confirmed by a prospective registry.

Entities:  

Mesh:

Year:  2007        PMID: 18004634     DOI: 10.1007/s00415-007-0754-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  59 in total

1.  Fulminant multiple sclerosis.

Authors:  G Niebler; T Harris; T Davis; K Roos
Journal:  AJNR Am J Neuroradiol       Date:  1992 Nov-Dec       Impact factor: 3.825

2.  Balò's concentric sclerosis: MRI.

Authors:  C J Chen; L S Ro; L J Wang; Y C Wong
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

3.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

4.  Balo's concentric sclerosis: value of magnetic resonance imaging in diagnosis.

Authors:  S Singh; A Kuruvilla; M Alexander; I P Korah
Journal:  Australas Radiol       Date:  1999-08

Review 5.  Pitfalls in the diagnosis of brain tumours.

Authors:  Antonio Mp Omuro; Claudia C Leite; Karima Mokhtari; Jean-Yves Delattre
Journal:  Lancet Neurol       Date:  2006-11       Impact factor: 44.182

6.  Serial magnetic resonance imaging (MRI) study of a patient with Balo's concentric sclerosis treated with immunoadsorption plasmapheresis.

Authors:  Y Sekijima; T Tokuda; T Hashimoto; C S Koh; S Shoji; N Yanagisawa
Journal:  Mult Scler       Date:  1997-01       Impact factor: 6.312

7.  Late-onset multiple sclerosis mimicking brain tumor: a case report.

Authors:  Kazuhisa Iwamoto; Hidehiro Oka; Satoshi Utsuki; Tatsuya Ozawa; Kiyotaka Fujii
Journal:  Brain Tumor Pathol       Date:  2004       Impact factor: 3.298

8.  Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients.

Authors:  J J Kepes
Journal:  Ann Neurol       Date:  1993-01       Impact factor: 10.422

9.  Fulminant form of multiple sclerosis simulating brain tumor: a case with parkinsonian features and pathologic study.

Authors:  P A Maranhão-Filho; L Moraes Filho; L S Camara; C C Salema
Journal:  Arq Neuropsiquiatr       Date:  1995-09       Impact factor: 1.420

Review 10.  The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis.

Authors:  F Fazekas; F Barkhof; M Filippi; R I Grossman; D K Li; W I McDonald; H F McFarland; D W Paty; J H Simon; J S Wolinsky; D H Miller
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

View more
  14 in total

1.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

Review 2.  Differential imaging of atypical demyelinating lesions of the central nervous system.

Authors:  Matteo Paoletti; Shaun Ivan Muzic; Francesca Marchetti; Lisa Maria Farina; Stefano Bastianello; Anna Pichiecchio
Journal:  Radiol Med       Date:  2021-01-24       Impact factor: 3.469

Review 3.  The radiologically isolated syndrome: look (again) before you treat.

Authors:  Rebecca Spain; Dennis Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

Review 4.  [Demyelinating disorders].

Authors:  T Weber; W Köhler
Journal:  Nervenarzt       Date:  2010-04       Impact factor: 1.214

5.  Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.

Authors:  Mirja Wallner-Blazek; Alex Rovira; Massimo Fillipp; Mara A Rocca; David H Miller; Klaus Schmierer; Jette Frederiksen; Achim Gass; Hugo Gama; Charles P Tilbery; Antonio J Rocha; José Flores; Frederik Barkhof; Alexandra Seewann; Jacqueline Palace; Tarek Yousry; Xavier Montalban; Christian Enzinger; Franz Fazekas
Journal:  J Neurol       Date:  2013-04-26       Impact factor: 4.849

6.  Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions.

Authors:  Sherifa A Hamed
Journal:  World J Clin Cases       Date:  2015-06-16       Impact factor: 1.337

7.  Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline.

Authors:  R Vitorino; S-P Hojjat; C G Cantrell; A Feinstein; L Zhang; L Lee; P O'Connor; T J Carroll; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-19       Impact factor: 3.825

Review 8.  Differential diagnosis of white matter lesions: Nonvascular causes-Part II.

Authors:  S Weidauer; M Nichtweiss; E Hattingen
Journal:  Clin Neuroradiol       Date:  2014-02-12       Impact factor: 3.649

9.  Fulminant demyelinating diseases.

Authors:  Megan R Rahmlow; Orhun Kantarci
Journal:  Neurohospitalist       Date:  2013-04

10.  Differential diagnosis of a vanishing brain space occupying lesion in a child.

Authors:  Sherifa A Hamed; Mohamad A Mekkawy; Hosam Abozaid
Journal:  World J Clin Cases       Date:  2015-11-16       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.